FTSE Russell Analytics

content.title.value
FTSE Russell Analytics

PDF, 453.95KB, 4 pages

Download
Download

Share price analysis relative to sector and index performance.

Company tear sheet

content.image.label
Company tear sheet

PDF, 59.25KB, 7 pages

Download
Download

Full issuer details available in a single file ready for sharing.

Faron Pharmaceuticals Oy news

Show all news
Sort by
Show 20 news
128 results (20 showing)
HeadlineSourceDateTime
Faron to Present at Jefferies Conference 2021
Reach
16 November 2021
07:00:12
Reach 16.11.21 07:00:12
Faron awarded EUR 3.8 Million in Arbitration Case
RNS
09 November 2021
07:00:03
RNS 09.11.21 07:00:03
Cellular and Molecular Life Sciences Publication
Reach
03 November 2021
15:55:01
Reach 03.11.21 15:55:01
Exercise of options
RNS
07 October 2021
07:00:06
RNS 07.10.21 07:00:06
Holding(s) in Company
RNS
05 October 2021
11:30:07
RNS 05.10.21 11:30:07
Registration of Placing Shares with Trade Register
RNS
01 October 2021
14:00:01
RNS 01.10.21 14:00:01
Results of Placing and Issue Price
RNS
01 October 2021
07:00:07
RNS 01.10.21 07:00:07
Proposed Issue and Placing of Shares
RNS
30 September 2021
16:31:33
RNS 30.09.21 16:31:33
Presentation of Updated MATINS Data at ESMO
RNS
17 September 2021
07:00:03
RNS 17.09.21 07:00:03
Faron Announces Presentation at ESMO Congress
Reach
09 September 2021
07:00:08
Reach 09.09.21 07:00:08
Faron to Present at H.C. Wainwright Conference
Reach
07 September 2021
07:00:04
Reach 07.09.21 07:00:04
Half-Year Financials, January 1 – June 30 2021
RNS
26 August 2021
07:00:01
RNS 26.08.21 07:00:01
First Patient Dosed in Phase II/III COVID-19 Trial
RNS
25 August 2021
07:00:02
RNS 25.08.21 07:00:02
Notice of Half-Year Report
RNS
28 July 2021
07:00:09
RNS 28.07.21 07:00:09
Faron to Host KOL Webinar on Clever-1 Receptor
Reach
12 July 2021
07:00:08
Reach 12.07.21 07:00:08
Updated corporate presentation
RNS
22 June 2021
07:00:03
RNS 22.06.21 07:00:03
Second Price Monitoring Extn
RNS
14 June 2021
11:05:54
RNS 14.06.21 11:05:54
Price Monitoring Extension
RNS
14 June 2021
11:00:18
RNS 14.06.21 11:00:18
Bexmarilimab granted key US patent
RNS
14 June 2021
07:00:07
RNS 14.06.21 07:00:07
Bexmarilimab results published in CCR
RNS
03 June 2021
07:00:06
RNS 03.06.21 07:00:06